Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
158.73
-4.33 (-2.66%)
At close: Apr 28, 2026, 4:00 PM EDT
158.73
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.24 billion as of April 28, 2026. Its market cap has increased by 230.55% in one year.
Market Cap
6.24B
Enterprise Value
5.79B
1-Year Change
230.55%
Ranking
Category
Stock Price
$158.73
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.24B, an increase of 4,219.26%. That is a compound annual growth rate of 156.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.41B | 6.90% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 6.75B |
| Erasca | 6.68B |
| Protagonist Therapeutics | 6.38B |
| Apogee Therapeutics | 6.32B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 6.01B |
| Cogent Biosciences | 5.93B |